AMAT vs DHR: Which Is the Better Buy?
Side-by-side comparison of Applied Materials, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Applied Materials, Inc. · Technology
$603.04
-45.0% upside to fair value
Grade C
High Quality
VS
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
DHR trades at a lower forward P/E
(37.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AMAT |
DHR |
| Current Price |
$603.04 |
$195.98 |
| Fair Value Estimate |
$331.67 |
$211.54 |
| Upside to Fair Value |
-45.0%
|
+7.9%
|
| Market Cap |
$478.8B |
$138.7B |
| Forward P/E |
56.4x
|
37.8x
|
| EV / EBITDA |
43.0x
|
22.8x
|
| Price / Sales |
16.5x
|
5.6x
|
| Price / FCF |
80.3x
|
26.2x
|
| Revenue Growth YoY |
+11.4%
|
+3.7%
|
| Gross Margin |
49.0%
|
60.7%
|
| Operating Margin |
29.5%
|
21.0%
|
| Return on Equity |
39.8%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.25%
|
3.81%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Applied Materials, Inc. is a leading semiconductor equipment company with a strong competitive moat in multiple wafer fab equipment segments, driven by its scale, infrastructure, and technology leadership in AI-critical process steps. The company benefits from a seasoned management team led by CEO Gary Dickerson, who has over 12 years at the helm and a track record of strong revenue and profitabi…
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Accumulation Zones
| Metric |
AMAT |
DHR |
| Zone Low |
$248.75 |
$158.66 |
| Zone High |
$281.92 |
$179.81 |
| In Buy Zone? |
No
|
No
|